| 1-Bromo-2-butyne |
3355-28-0 |
IHS |
| 1-Hexyne |
693-02-7 |
IHS |
| 1-Heptane |
142-82-5 |
IHS |
| 3-Butyne-1-ol |
927-74-2 |
IHS |
| 2-Pentyne-1-ol |
6261-22-9 |
IHS |
| 3-Octyne-1-ol |
14916-80-4 |
IHS |
| 4-Pentyn-1-ol |
5390-04-5 |
IHS |
| 7-Octyne-1-ol |
871-91-0 |
IHS |
| 4-Nitro benzyl cyanide |
555-21-5 |
IHS |
| 5-Hexynoic acid |
53293-00-8 |
IHS |
| 1-Hexanol |
111-27-3 |
IHS |
| 2-Octyn-1-oL |
20739-58-6 |
IHS |
| 5-Bromo-1-Pentyne |
120-93-4 |
IHS |
| Para Bromo toluene |
106-38-7 |
IHS |
| Di-t-butyl N,N-Diethylphosphoramidite |
117924-33-1 |
IHS |
| 4-Bromo-2-fluoroaniline |
367-24-8 |
Vandetanib |
| 4-Amino-2-fluoro-N-methylbenzamide |
915087-25-1 |
Enzalutamide |
| N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide |
90357-51-0 |
Bicalutamide |
| 1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid |
862574-88-7 |
Lumacaftor |
| 2-Chloro-1-((3-fluorobenzyl)oxy)-4-nitrobenzene |
443882-99-3 |
Lapatinib |
| 3-(Pyridin-2-ylamino)-propionic acid ethyl ester (DAG-1) |
103041-38-9 |
|
| Dabigatran Intermediates |
| 3-(Pyridin-2-ylamino)-propionic acid ethyl ester (DAG-1) |
103041-38-9 |
|
| 4-Methylamino-3-nitro-benzoic acid (DBG-1) |
41263-74-5 |
|
| 3-[(3-Amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]-propionic acid ethyl ester (DAG-2) |
212322-56-0 |
|
| N-(4-Cyanophenyl)-glycine |
42288-26-6 |
|
| 4-Aminobenzene-1-carboximidamide dihydrochloride |
2498-50-2 |
|
| Hexyl(Z)-amino(4-aminophenyl)methylidene carbamate Hydrochloric Acid |
1307233-93-7 |
|
| Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido) propanoate (DEM-1) |
211915-84-3 |
|
| Ethyl-3-(2-((4-amidinophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido) propanoate |
429658-95-7 |
|
| 3-[(2-Chloromethyl-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
1307233-94-8 |
|
| N-[[2-[[4-[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl-N-2-pyridinyl-β-alanine ethyl ester (DAB N-1) |
211915-06-9 |
|
| Vildagliptin Intermediates |
| 3-Amino-1-adamantanol |
702-82-9 |
|
| (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile |
207557-35-5 |
|
| Apixaban Intermediates |
| (Z)-Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono) acetate |
27143-07-3 |
|
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |
503615-03-0 |
|
| 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone |
1267610-26-3 |
|
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one |
545445-44-1 |
|
| Finerenone Intermediates |
| 4-Cyano-2-methoxybenzaldehyde |
21962-45-8 |
|
| 4-Amino-5-methylpyridin-2-ol |
95306-64-2 |
|
| 2-Cyanoethyl 3-oxobutanoate |
65193-87-5 |
|
| Regular Intermediates |
| 5-(4-Fluorophenyl)-5-oxopentanoic acid |
149437-76-3 |
|
| Amino acetaldehyde dimethyl acetal |
22483-09-6 |
|
| 2-Chloropyrimidine |
1722-12-9 |
|
| 5-Bromo-2-chloropyrimidine |
53939-30-3 |
|
| (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one |
63095-51-2 |
|
| 2-(Triphenylphosphoranylidene)acetaldehyde |
2136-75-6 |
|
| 5-Bromoindole |
10075-50-0 |
|
| Dimethyl [3-(3-chlorophenoxy)-2-oxopropyl] phosphonate |
40665-94-9 |
|
